Peptide antisera specific for either the aminoor carboxyl-terminal regions of villin were used to locate the position of cysteine residues in immunoblots of villin cleaved with 2-nitro-5-thiocyanobenzoic acid. Maps constructed from the cleavage pattern suggest that villin contains six cysteine residues, two located in its amino-terminal peptide of Mr 44,000, and four located in the carboxyl-terminal peptide ofMr 51,000. Gel overlays of the partial cleavage fragments with '2SI-labeled actin identified a calcium-dependent actin-binding region located within the amino-terminal peptide of Mr 32,000 of villin. The peptide antibody method used, called cleavage mapping, should be a convenient technique for mapping residues and ligand binding sites in proteins.
Villin, a Mr 95,000 actin-binding protein of the intestine microvillus cytoskeleton, is unusual because it possesses two types of actin-binding activities. In calcium concentrations >1 ,uM villin severs actin filaments into short lengths while in calcium concentrations <1 ,uM villin crosslinks actin filaments into bundles (1) (2) (3) (4) . Understanding the mechanism of filament severing and bundling requires identification of the villin-, actin-, and calcium-binding sites.
Villin is cleaved by V8 protease into two fragments, villin core (Mr 87,000) and villin headpiece (Mr 8500). Villin core and headpiece retain the amino and carboxyl termini ofvillin, respectively. Glenney and co-workers (5, 6) have shown that a calcium-dependent actin-filament-severing activity is located in villin core. The villin headpiece exhibited calciumindependent actin-binding but not -bundling or -severing activity. Villin contains three calcium-binding sites, one of which is nonexchangeable. One of the exchangeable calcium-binding sites is located in villin core, while the other exchangeable site is located in villin headpiece (7, 8) . We have extended these studies and shown that trypsin produces a Mr 44,000 amino-terminal fragment of villin (named 44T), which retains the calcium-dependent actin-severing activity (9) . The calcium dependence of the binding activity suggests that the exchangeable calcium-binding site in villin core is located within the amino-terminal peptide of Mr 44,000.
Although our studies locate an actin-and calcium-binding region within the amino-terminal half of villin, much smaller binding fragments are required to refine further the regulation of actin binding by calcium.
To map such binding regions easily and accurately, we have devised a peptide antibody method for localizing certain amino acids and fragments within the molecule. In our approach we have used polyclonal antisera, which recognize either the NH2-terminal or COOH-terminal regions of villin, to locate the positions of the cysteine residues in villin. This technique, which we call cleavage mapping, is generally useful for identifying the positions of certain other amino acids, chemical modification sites, ligand binding sites, and chemical or proteolytic fragments. The map of the cysteine residues has enabled us to identify a calcium-regulated actin-binding domain within an amino-terminal villin peptide of Mr 32,000.
MATERIALS AND METHODS Proteins. Villin was purified from chicken intestine epithelia using the procedure described by Bretscher & Weber (1) . The villin proteolytic fragments (villin core, 51T, and 44T) were purified as described (9) . Actin was purified from rabbit skeletal muscle by using the procedure of Taylor and Weeds (10). 2-Nitro-5-thiocyanobenzoic acid (NTCB) was obtained from Sigma.
Further treatment of the 44T fragment of villin with trypsin produces a Mr 14,000 peptide, named 44T-14T. Digestion at longer times produces a Mr 13,000 peptide, named 44T-13T. Both peptides were purified by CM-52 and Affigel Blue column chromatography (to be reported elsewhere), and the first 20 residues of each fragment were sequenced by Edman degradation using a modified Beckman 890B automated sequencer (11) .
Preparation of Antigen. The peptide Val-Glu-Leu-Ser-LysLys-Val-Thr-Gly-Lys-Thr-Thr-Tyr-Gly was assembled and cleaved as described by Atherton et al. (12) . The synthetic peptide was coupled to keyhole limpet hemocyanin using bisdiazotized o-tolidine, and excess reagents were removed by dialysis against phosphate-buffered saline (13) .
Peptide Antisera Production. Antisera were raised in rabbits by injecting 1 mg of the peptide-hemocyanin conjugate in complete Freund's adjuvant at multiple sites on the back. This was followed by injections at 2-week intervals in incomplete Freund's adjuvant. The rabbits were exsanguinated at week 10. The titers of the antisera were quantified by ELISA using either the synthetic peptide or undenatured villin adsorbed to microtiter plates. Swine anti-rabbit IgG coupled to peroxidase (Dakopatts) was used as the secondary antibody. The plates were developed with diaminobenzidine, and absorbance was monitored at 490 nm. The specificity of the antisera (R211.3) was determined from immunoblots (14) against villin proteolytic fragments. Antisera (R200.2) against the villin headpiece peptide were described (9) .
Quantitation of Cysteine Residues. Villin or its proteolytic fragments was reduced and the cysteine residues were carboxymethylated with iodo[2-14C]acetic acid or iodo [1- 14C]acetamide (Amersham) (15) . Incorporation of radioactivity was quantitated by liquid scintillation counting. The number of cysteine residues was calculated from the specific activity of the radiolabeled villin.
Proc. NatL Acad Sci USA 82 (1985) 6789 Cysteine content was also measured by 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) titration (16) in either NaDodSO4 or 6 M guanidine HCl. NTCB Cleavage. Villin was reduced and denatured by dialysis into 6 M guanidine-HCl/10 mM dithiothreitol/0.1 mM EDTA at 370C. After 6-12 hr, the sample was rapidly desalted against 6 M guanidine-HCl/0.2 M Tris-HCl (pH 8.0)/0.1 mM dithiothreitol/0.1 mM EDTA. The protein concentration was determined by absorbance at 280 nm using an absorptivity of 1.28 liters/g-cm (7). The reduced and denatured villin was cleaved with NTCB (17, 18) . NTCB was dissolved in 50 mM sodium phosphate, pH 7.6, mixed with villin at a 5-fold excess over total thiols, and incubated in the dark at 370C. The reaction was quenched after different times by adding acetic acid to 50o (vol/vol) and the cleaved products were dialyzed against 10%6 acetic acid (vol/vol) in M, 3500 cutoff dialysis tubing. The cleavage products were lyophilized and stored at -20'C. As control experiments, villin was either incubated in the absence of NTCB under reduced and denaturing conditions or reduced, denatured, carboxymethylated, and then incubated with NTCB. The cleavage fragments of villin were electrophoresed in NaDodSO4 on 10% or 10-22.5% polyacrylamide microslab gels (19) .
Cleavage Mapping. The NTCB cleavage fragments of villin were electrophoresed on 1o NaDodSO4/polyacrylamide microslab gels and were immunoblotted with rabbit polyclonal antisera specific for the amino terminus (R211.3) or the headpiece region (R200.2) at a dilution of 1:200 or 1:2000, respectively. The filters were incubated at a 1:400 dilution with swine anti-rabbit IgG coupled to peroxidase and then were developed with 4-chloro-1-naphthol. The molecular weights of the peptides were calculated from their electrophoretic mobility on NaDodSO4/polyacrylamide gels using markers with Mr 95,000, 77,000, 66,300, 45,000, 25,700, and 17,200.
"2SI-Labeled Actin Gel Overlay. NTCB fragments which bound actin were identified using 125I-labeled actin (20) . The fragments and villin proteolytic markers were electrophoresed on 10% microslab gels. The gels were incubated with 1251-labeled actin in buffer containing either 1 mM EGTA or 0.2 mM CaCl2 and then processed for autoradiography.
RESULTS
The rationale we followed for mapping cleavage sites is illustrated in Fig. 1 for a hypothetical protein Mr 100,000 that contains two cleavage sites (Fig. la) . Limited or partial cleavage at these sites (Fig. lb) Characterization of Amino-Terminal Specific Antiserum. We synthesized the peptide Val-Glu-Leu-Ser-Lys-Lys-ValThr-Gly-Lys-Thr-Thr-Tyr-Gly. This peptide represents the amino-terminal 12 residues of villin (9) followed by Tyr-Gly. The synthetic peptide was crosslinked through its tyrosine residue to hemocyanin and the mixture was injected into rabbits. The antiserum recognized undenatured villin and the synthetic peptide (Fig. 2a) .
The specificity of the antiserum to the amino terminus was tested by immunoblots containing villin proteolytic fragments whose locations in the protein have been characterized by protein sequencing (Fig. 2b, lane 1) . The antiserum (lane 2) recognized villin, villin core, and 44T. The amino termini of these fragments have been confirmed by sequence analysis, and all contain the villin amino terminus. As expected, this antiserum did not recognize the 51T fragment, which comes from the carboxyl-terminal end of the protein. Our characterized villin headpiece antiserum (9) recognized villin and 51T but not villin core or 44T (lane 3). We isolated two small tryptic fragments of 44T (Mr 14,000 and 13,000) and sequenced their amino termini. The larger fragment, 44T-14T, retained the original amino terminus of villin while the smaller fragment, 44T-13T, started at the lysine residue at position 6. Using these fragments the specificity of the amino-terminal antisera was checked on immunoblots (Fig. 2c, lanes 4-7) , and it was found that the antiserum recognized only the fragment with the intact amino terminus. Loss of the amino-terminal five residues eliminated all detectable antibody binding.
Quantitation of Cysteine Residues. Because villin has not been completely sequenced, we did not know the number of cysteine residues in the protein. Furthermore, cysteine content cannot be reliably quantified from amino acid analysis. Therefore, we measured cysteine content with two methods, carboxymethylation and the DTNB reaction. Our measurements (Table 1) indicate one or two cysteine residues in the amino-terminal peptide of Mr 44,000, two or three in the carboxyl-terminal peptide of Mr 51,000, and three or four residues in the intact protein. However, since cysteine residues are easily oxidized, our measurements of cysteine content represent only a minimum estimate.
Partial NTCB Cleavage. Villin was cleaved by NTCB (Fig.  3) occur at residues other than cysteine. The control experiments showed little cleavage occurred under conditions which had produced the NTCB cleaved fragments.
Cysteine Cleavage Map. The NTCB cleavage fragments of villin (Fig. 4 (Fig. 4) Mapping Actin-Binding Sites. The NTCB cleavage fragments were overlaid with 125I-labeled actin (Fig. 5) in the presence of EGTA (lanes 1-3) or calcium (lanes 4-6) . The radiolabeled actin recognized a set of NTCB-cleaved fragments, as well as previously characterized proteolytic fragments, only when incubated in buffers containing calcium (lanes D-F). The smallest fragment that bound actin was Mr 32,000 (lane F). The number and sizes of the actin-detected fragments was similar to the pattern obtained with immunoblots using the amino-terminal-specific antisera and suggests that a calcium-dependent actin-binding region is located within the amino-terminal peptide of Mr 32,000 of villin. However, within this region lies a cysteine residue located in an amino-terminal peptide of Mr 10,000. We were Proc. Nad Acad ScL USA 82 (1985) Proc. NatL Acad Sci USA 82 (1985) unable to detect actin binding to either the Mr 10,000 or Mr 22,000 fragments that would be produced by cleavage at this site.
DISCUSSION
Previously we purified a Mr 44,000 amino-terminal fragment of villin and showed this fragment retained a calciumregulated actin-severing activity (9) . In this report we use a different approach to locate a calcium-regulated actin-binding region within the amino-terminal Mr 32,000 peptide of villin. Furthermore, our studies show that cleavage at the cysteine residue located in an amino-terminal Mr 10,000 peptide inhibits actin binding and, thus, suggests that this region is important for villin function. This suggestion is consistent with our preliminary biochemical studies on the 44T-14T fragment. This fragment retains the amino terminus of villin and displays a calcium-regulated actin-depolymerizing activity similar to villin and 44T as measured by pelleting assays (unpublished data).
With antibodies specific for either terminus of villin, we have identified the number and location of the NTCB cleavage sites. Our assignment of cysteine residues will only be confirmed when the amino acid sequence of villin is completed. However, the number of cysteine residues mapped in the 44T and 51T domains of villin is similar to the number of cysteine residues calculated for each domain by carboxymethylation and DTNB titration. Because cysteine residues are easily oxidized, quantitation of these residues by conventional biochemical methods can lead to an underestimate of their number. The peptide antibody method is an integral counting method with the same advantages as the chemical modification methods described by others (21) (22) (23) .
Other methods for mapping cleavage sites have been described that involve either metabolic labeling of the carboxyl terminus (24) or Edman degradation and labeling of the amino terminus (25) . These methods are direct and thus offer advantages such as speed and simplicity. Although our method requires the lengthy preparation of amino-and carboxyl-terminal peptides and production of antisera, there are particular advantages of this approach. One advantage of the peptide antibody approach is that cleavage maps can be produced from either or both ends of the protein even from proteins with blocked amino termini. Mapping from both ends increases the accuracy of the cleavage map. Since the peptide antibody method is very sensitive because of amplification by the second antibody, the number and positions of the cleavage sites can be calculated even if the efficiency of cleavage is low and few fragments are produced. A third advantage ofthis method is that specific antisera should allow mapping studies in the presence of other proteins. This feature might allow binding regions to be mapped directly in protein complexes or cellular structures in vitro and in vivo by using an approach involving protection from chemical modification. In addition, the peptide antibody approach allows us to map 
